Combination treatment may help cut lifelong ibrutinib for chronic lymphocytic leukemia patients

Combination treatment may help cut lifelong ibrutinib for chronic lymphocytic leukemia patients

Chronic lymphocytic leukemia (CLL) is the most prevalent adult leukemia in the Western Hemisphere, affecting approximately 200,000 people in the United States…
Read More

Leave a Reply

Your email address will not be published. Required fields are marked *